Skip to main content

Table 3 Comparison between active patients with patients in remission or mild activity

From: Serum Interleukin-34 in Psoriatic arthritis patients and its correlation with disease 1 activity, and subclinical atherosclerosis

 

Active patients (22)

Patients in remission or mild activity (48)

P value

Age (years)

41.7 ± 4.9

40.2 ± 5.8

0.29

BMI

28.2 ± 2.1

27.6 ± 2.1

0.27

Duration of PSA (years)

3.77 ± 1.5

3.71 ± 1.4

0.87

DAPSA score

13.5 ± 4.7

9.7 ± 4.6

0.002*

ESR (mm/h)

27.9 ± 8.7

28.5 ± 11.3

0.82

hs-CRP (mg/dL)

9.6 ± 3.2

8.2 ± 2.4

0.04*

Serum IL-34 (ng/L)

2031.7 ± 540.7

1693.8 ± 658.5

0.04*

cIMT ( mm)

0.92 ± 0.31

0.66 ± 0.29

0.001*

  1. PSA psoriatic arthritis, ESR erythrocyte sedimentation rate, hsCRP highly sensitive C-reactive, cIMT carotid intima media thickness, DAPSA Disease Activity index for Psoriatic Arthritis, BMI body mass index
  2. Significant value*: P < 0.05